— Why it moved
Why BDRX Stock Jumped and Faded Today — September 11, 2026
Biodexa Pharmaceuticals got hit with massive day-trader volume after posting earnings that highlighted zero revenue and an urgent cash crunch.
What moved BDRX stock
Biodexa Pharmaceuticals is a clinical-stage biotech developing targeted oncology drugs. The company released interim financial results showing zero revenue, a narrowing net loss caused mostly by non-cash accounting gains, and an explicit going concern warning. It also filed a prospectus supplement covering the potential resale of tens of millions of shares.
The mechanics
A micro-float of 594,400 shares and a sub-$700k market cap made this prime ground for a momentum squeeze. Over 142 million shares traded, churning the entire float more than two hundred times over.
BDRX by the numbers
The alert window
The alert dropped at 10:40 AM at $1.18. Anyone following live had to stomach an immediate 8% drop to $1.09 before the buyers pushed it to $1.55 at 1:09 PM. That was a 30.8% move to the top over 149 minutes if you managed the drawdown.
How BDRX's move ended
It gave up plenty of ground after the afternoon peak, closing at $1.29 to hold an 8.9% gain from the alert. With dilution hanging overhead and financing needed before year-end, this was just day-trading churn.
The tell: When a micro-cap surges on zero revenue and a going concern warning, you trade the volume spike, not the company.